Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Charite University, Berlin, Germany | OTHER |
| German Diabetes Foundation, Munich, Germany | UNKNOWN |
| Ernst von Bergmann Hospital | OTHER |
| University Hospital Tuebingen |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
High intake of insoluble fiber is strongly associated with a reduced incidence of diabetes and cardiovascular events in prospective observation studies. Our primary objective is to compare a life style diabetes prevention program(PRAEDIAS) with and without added insoluble fibers in its effectiveness to prevent incident diabetes type 2 in high risk individuals with impaired glucose tolerance. Subjects with IGT not willing to participate in the intervention will be used as independent controls. Secondary aims are to identify mechanisms of action with regard to body composition, anti-inflammatory and metabolic effects of fibers. We propose a randomized, prospective intervention study. The results will be of general relevance for guidance of fiber intake in the population and will help the food industry to design healthy high fiber foods. Fiber can be added at low cost to numerous foods. Increased fiber intake may therefore provide a simple non-cognitive prevention strategy effective at the population level.
The overall objective is to investigate whether insoluble fibers added to standard nutrition can reduce the progression of impairment of glucose metabolism in a high risk population with impaired glucose metabolism. Large prospective cohort studies clearly show that mainly insoluble cereal fiber from whole grains is associated with reduced risk of type 2 diabetes and cardiovascular disease. However, there is a lack of evidence from prospective intervention studies targeted to evaluate the potential of dietary fibers to reduce diabetes and cardiovascular disease as recently stated by the Cochrane Foundation. Dietary fiber intake is generally much lower than currently recommended, which may in part be related to side effects of whole grain nutrients and their gustatory properties. Intestinally uncomfortable effects are at least partly related to fermentation which is much less induced by insoluble non-fermentable fibers than by soluble fermentable fibers. The prospective demonstration of beneficial effects of insoluble fibers in preventing diabetes type 2 will allow detailed nutritional recommendations. This may serve to support the consumption of metabolically beneficial constituents of fiber-rich diets and help to increase fiber intake by high fiber natural nutrients or everyday nutrients enriched in insoluble natural fibers.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Drink enriched in fibers | Experimental | 7,5g enriched fiber drinks, BID |
|
| Placebo drink | Experimental | Placebo drink, BID |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Fiber | Dietary Supplement | 200ml drinks enriched with 7,5g of fiber (90% insoluble fiber, 10% soluble fiber), BID, over 24 months |
|
| Measure | Description | Time Frame |
|---|---|---|
| Change of 2h-postprandial blood glucose from IGT to diabetes mellitus type 2 or normal glucose tolerance (NGT) | Change of the glucose metabolism (OGTT) | 0, 12, 24 months |
| Measure | Description | Time Frame |
|---|---|---|
| Change of insulin sensitivity | Measurement by HOMA and OGIS from the OGTT | 0, 12, 24 months |
| Change of insulin secretion | Measurement by the OGTT |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Andreas FH Pfeiffer, Prof. | German Institute of Human Nutrition Potsdam-Rehbruecke | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| German Instiute of Human Nutrition | Potsdam-Rehbruecke | Nuthetal | 14558 | Germany | ||
| Charite University |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 41624204 | Derived | Kabisch S, Montagna F, Honsek C, Kemper M, Gerbracht C, Arafat AM, Birkenfeld AL, Dambeck U, Osterhoff MA, Weickert MO, Floel A, Pfeiffer AFH. Effects of lifestyle intervention and supplementation with insoluble oat fiber on cognitive functions in patients with prediabetes: a secondary analysis of the Optimal Fiber Trial. Front Nutr. 2026 Jan 16;12:1699958. doi: 10.3389/fnut.2025.1699958. eCollection 2025. | |
| 29492637 |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D003920 | Diabetes Mellitus |
| D009748 | Nutrition Disorders |
| D009765 | Obesity |
| D050177 | Overweight |
| D024821 | Metabolic Syndrome |
| D001835 | Body Weight |
| D044882 | Glucose Metabolism Disorders |
| D008659 | Metabolic Diseases |
| D015431 | Weight Loss |
| ID | Term |
|---|---|
| D009750 | Nutritional and Metabolic Diseases |
| D004700 | Endocrine System Diseases |
| D044343 | Overnutrition |
| D012816 | Signs and Symptoms |
Not provided
Not provided
| ID | Term |
|---|---|
| D004043 | Dietary Fiber |
| ID | Term |
|---|---|
| D004040 | Dietary Carbohydrates |
| D002241 | Carbohydrates |
| D005502 | Food |
| D000066888 | Diet, Food, and Nutrition |
Not provided
Not provided
| OTHER |
Not provided
Not provided
Not provided
Not provided
| Placebo | Dietary Supplement | 200ml Placebo, BID, over 24 months |
|
| 0, 12, 24 months |
| Expression of inflammatory markers in blood | CRP, leukocytes, adipocytokines | 0, 6, 12, 18, 24 months |
| Biometric data | Nutritional impact of blood pressure, anthropometry (body weight and body composition) | 0, 6, 12, 18, 24 months |
| Assessment of cognitive performance | 0, 12, 24 months |
| Development of indices for the prediction of fat mass | Change of fat fraction in liver, abdominal and in the total body fat measuring by MRI/H1-spectroscopy | 0, 12, 24 months |
| Determination of gene expression in adipose tissue | Determination of inflammatory and other transcripts in sc adipose tissue in a fat biopsy. | 0, 12, 24 month |
| Berlin |
| State of Berlin |
| 12200 |
| Germany |
| Derived |
| Honsek C, Kabisch S, Kemper M, Gerbracht C, Arafat AM, Birkenfeld AL, Dambeck U, Osterhoff MA, Weickert MO, Pfeiffer AFH. Fibre supplementation for the prevention of type 2 diabetes and improvement of glucose metabolism: the randomised controlled Optimal Fibre Trial (OptiFiT). Diabetologia. 2018 Jun;61(6):1295-1305. doi: 10.1007/s00125-018-4582-6. Epub 2018 Feb 28. |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D007333 | Insulin Resistance |
| D006946 | Hyperinsulinism |
| D001836 | Body Weight Changes |
| D010829 |
| Physiological Phenomena |
| D019602 | Food and Beverages |